Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phlogenzym in Acute Thrombophlebitis
NCT03470337Phase 3Completed
- Sponsor
- Mucos Pharma
- Start
- Sep 1996
- Primary completion
- Jun 1997
- Modality
- Therapeutic Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trypsin + bromelain + rutoside in superficial thrombophlebitis (SVT), sponsored by Mucos Pharma. Started Sep 1996; status: completed.
02
Drugs
trypsin + bromelain + rutoside
03
Conditions
superficial thrombophlebitis (SVT)
Beyond the preview
Go deeper on NCT03470337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03470337.